Revvity secures FDA clearance for total testosterone immunoassay
Revvity has received clearance from the US Food and Drug Administration (FDA) for its total testosterone automated chemiluminescence immunoassay (ChLIA)…
News
Osel and partners launch Phase IIb FLIP-2 trial of Lactin-V
Pfizer receives EC approval for Hympavzi to treat haemophilia
Roche’s Elecsys pTau217 blood test secures CE mark for Alzheimer’s
Alkermes reports encouraging data from Phase III study of Lumryz
Isomorphic Labs receives $2.1bn for AI drug development
HeartBeam commences pilot study of new 12-lead ECG patch
Inhibrx announces positive interim results from HexAgon trial
